Back to search
FDAFDA · Food and drugs·Recall number D-0638-2017

Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, For Intravenous Use, packaged in 100 mL glass vial, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6510-01

Published April 12, 2017 · Recall initiated: January 24, 2017

Summary

FDA records drug Class I recall D-0638-2017, published April 12, 2017 and initiated January 24, 2017. Recalling firm: Hospira Inc., A Pfizer Company; Status: Terminated; Reported quantity: 30,880 vials; Lot: Lot # 591053A, Exp 11/1/2017. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc., A Pfizer Company
Distributor
U.S. Nationwide
Lot
Lot # 591053A, Exp 11/1/2017
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Direct Infusion, For Intravenous Use, packaged in 100 mL glass vial, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6510-01 recalled?

Yes. FDA published recall D-0638-2017 on April 12, 2017. Reported hazard: Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter